We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$5.86B
AUM Growth
+$813M
Cap. Flow
+$544M
Cap. Flow %
9.28%
Top 10 Hldgs %
50.44%
Holding
3,726
New
379
Increased
1,205
Reduced
834
Closed
278

Sector Composition

Rank Sector Weight
1 Energy 6.93%
2 Financials 4.55%
3 Technology 3.35%
4 Industrials 2.51%
5 Healthcare 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BELFA icon
2776
Bel Fuse Inc Class A
BELFA
$3.32B
$5K ﹤0.01%
273
BKU icon
2777
Bankunited
BKU
$3.38B
$5K ﹤0.01%
137
CENTA icon
2778
Central Garden & Pet Co Class A
CENTA
$2.41B
$5K ﹤0.01%
893
CII icon
2779
BlackRock Enhanced Captial and Income Fund
CII
$1B
$5K ﹤0.01%
400
-700
-64% -$9.43K
CRH icon
2780
CRH
CRH
$66.7B
$5K ﹤0.01%
+180
New +$4.46K
CSM icon
2781
ProShares Large Cap Core Plus
CSM
$509M
$5K ﹤0.01%
208
DIOD icon
2782
Diodes
DIOD
$4B
$5K ﹤0.01%
200
EPOL icon
2783
iShares MSCI Poland ETF
EPOL
$669M
$5K ﹤0.01%
172
EZPW icon
2784
Ezcorp Inc
EZPW
$1.82B
$5K ﹤0.01%
400
FANG icon
2785
Diamondback Energy
FANG
$57.6B
$5K ﹤0.01%
100
-150
-60% -$7.46K
FTEK icon
2786
Fuel Tech
FTEK
$48M
$5K ﹤0.01%
712
FXA icon
2787
Invesco CurrencyShares Australian Dollar Trust
FXA
$96.8M
$5K ﹤0.01%
60
-464
-89% -$43.1K
GIII icon
2788
G-III Apparel Group
GIII
$1.47B
$5K ﹤0.01%
+136
New +$4.08K
GOOD
2789
Gladstone Commercial Corp
GOOD
$627M
$5K ﹤0.01%
+300
New +$5.48K
LCTX icon
2790
Lineage Cell Therapeutics
LCTX
$257M
$5K ﹤0.01%
1,611
+1,239
+333% +$3.74K
MAG
2791
DELISTED
MAG Silver
MAG
$5K ﹤0.01%
1,000
-200
-17% -$1.08K
MATV icon
2792
Mativ Holdings
MATV
$448M
$5K ﹤0.01%
100
MKSI icon
2793
MKS Inc
MKSI
$22.2B
$5K ﹤0.01%
153
NBIX icon
2794
Neurocrine Biosciences
NBIX
$17.7B
$5K ﹤0.01%
+500
New +$4.88K
NGS icon
2795
Natural Gas Services Group
NGS
$470M
$5K ﹤0.01%
195
-105
-35% -$2.94K
NYT icon
2796
New York Times
NYT
$11.6B
$5K ﹤0.01%
300
-300
-50% -$4.08K
PRTA icon
2797
Prothena Corp
PRTA
$458M
$5K ﹤0.01%
201
-54
-21% -$1.35K
PSP icon
2798
Invesco Global Listed Private Equity ETF
PSP
$228M
$5K ﹤0.01%
80
+70
+700% +$4.21K
RHP icon
2799
Ryman Hospitality Properties
RHP
$8.4B
$5K ﹤0.01%
109
RMBS icon
2800
Rambus
RMBS
$10.4B
$5K ﹤0.01%
500
-300
-38% -$2.7K

Similar funds

Creative Planning's Q4 2013 Portfolio in Review

As of Q4 2013, Creative Planning held 3,726 positions worth $5.86B, up 16% from $5.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Creative Planning deployed $544M of net new capital in Q4 2013, opening 379 new positions and adding to 1,205 existing holdings. Its largest new stake was Allergan plc: 7,924 shares worth $1.33M.

By sector, the portfolio is most concentrated in Energy at 6.9% of assets, up from 6.3% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $77.7M trimmed.

  • Creative Planning's largest Q4 2013 buy was Allergan plc: 7,924 shares worth $1.33M.
  • Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q4 2013, an estimated $68.1M increase.
  • Creative Planning's biggest Q4 2013 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $77.7M.
  • Creative Planning fully exited Pioneer Municipal High Income Advantage Fund in Q4 2013, selling an estimated $1.95M.
  • Creative Planning's ten largest holdings make up 50% of its $5.86B portfolio in Q4 2013.
  • Creative Planning opened 379 new positions and closed 278 in Q4 2013.
  • Creative Planning's portfolio value rose 16% quarter-over-quarter to $5.86B.

Based on Creative Planning's 13F filing for Q4 2013, filed 6 Jan 2014.